Company profile

Epsilogen Ltd

Harnessing the power of IgE

Industry
Biotechnology
Employees
33
Headquarters
Hammersmith
Founded
2016
Office locations
1

Epsilogen Ltd company summary

Epsilogen Ltd is a company in the Biotechnology industry, headquartered in Hammersmith, founded in 2016. On LinkedIn the company has around 33 employees.

What technology does Epsilogen Ltd use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Epsilogen Ltd

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.

Where is Epsilogen Ltd located?

Epsilogen Ltd lists 1 location.

Hammersmith, W6 9RH, GBHQ
Waterfront

Compare companies similar to Epsilogen Ltd

More companies in Biotechnology.

CompanyIndustryEmployeesFoundedHeadquarters
Epsilogen Ltd
epsilogen.com
Biotechnology332016Hammersmith
Regeneron
regeneron.com
Biotechnology17,234-Tarrytown, New York
Bharat Biotech
bharatbiotech.com
Biotechnology2,0351996Hyderabad, Telangana
Biotechnology1,0232008Pune, Maharashtra
Biotechnology393-Bethesda, MD
Biotechnology2,6502004Chennai, India
Biotechnology6922001Cambé, PR
Organica Biotech
organicabiotech.com
Biotechnology1462000Mumbai, Maharashtra
Biotechnology2172017South San Francisco, California
Biotechnology2271971Lagoa Santa, Minas Gerais
Biotechnology2432015London, United Kingdom

Frequently asked questions about Epsilogen Ltd

What does Epsilogen Ltd do?

Epsilogen is a global leader in the development of immunoglobulin (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life. The company's lead programme targets the folate receptor alpha (FR alpha) and an anti-FR alpha IgE antibody is currently in a phase I trial to treat ovarian cancer. This is the world's first IgE therapeutic to enter the clinic.

How many employees does Epsilogen Ltd have?

Epsilogen Ltd has around 33 employees on LinkedIn.

Where is Epsilogen Ltd headquartered?

Epsilogen Ltd is headquartered in Hammersmith.

When was Epsilogen Ltd founded?

Epsilogen Ltd was founded in 2016.

Build a lead list from companies like Epsilogen Ltd

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.